Patent · US Expired

Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones

US7413754B2 · kind B2 · utility

0Cited by

12References

6Claims

0Family size

Assignee

Bionorica AG · DE

Inventors

Wolfgang Wuttke · Bovenden, DE
Hubertus Jarry · Witzenhausen, DE
Volker Christoffel · Meyenburg, DE
Barbara Spengler · Dresden, DE

Key dates

Filing date	Sep 16, 2002
Grant date	Aug 19, 2008
Priority date	—
Expiry date	Jul 1, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to extracts from Cimicifuga species and particularly from Cimicifuga racemosa, which are suited for producing a ready-formulated drug for the selective treatment and/or prophylaxis of sexual hormone-related disorders of the uro-genital tract. The extracts in accordance with the invention are moreover suited for the treatment and/or prophylaxis of post-menopausal urinary bladder infections. They are furthermore indicated for the treatment of benign and malignant prostate hyperplasies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.